Cargando…

Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail

BACKGROUND: With the introduction of direct acting antivirals, treatment of hepatitis C virus (HCV) in hard-to-reach populations is now feasible. Therefore, new cost-effective and reliable test methods are needed. Determination of HCV antibodies and HCV-RNA from dried blood spots samples could repre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neesgaard, Bastian, Ruhwald, Morten, Krarup, Henrik B., Weis, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067740/ https://www.ncbi.nlm.nih.gov/pubmed/30063765 http://dx.doi.org/10.1371/journal.pone.0201629

Ejemplares similares

Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
por: Neesgaard, Bastian, et al.
Publicado: (2017)

IP-10 Can Be Measured in Dried Plasma Spots in Patients with Chronic Hepatitis C Infection
por: Ruhwald, Morten, et al.
Publicado: (2012)

Can Not Be Sent by Mail
Publicado: (1895)

Use of IP-10 detection in dried plasma spots for latent tuberculosis infection diagnosis in contacts via mail
por: Villar-Hernández, R., et al.
Publicado: (2019)

Feasibility of self-sampled dried blood spot and saliva samples sent by mail in a population-based study
por: Sakhi, Amrit Kaur, et al.
Publicado: (2015)

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2015)

A Simple Method to Quantitate IP-10 in Dried Blood and Plasma Spots
por: Aabye, Martine G., et al.
Publicado: (2012)

Dried blood spot in the genotyping, quantification and storage of HCV RNA: a systematic literature review
por: Greenman, Jamie, et al.
Publicado: (2015)

Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper
por: Aabye, Martine G., et al.
Publicado: (2013)

Socioeconomic status in HCV infected patients – risk and prognosis
por: Omland, Lars Haukali, et al.
Publicado: (2013)

IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting
por: Hoel, Ida Marie, et al.
Publicado: (2019)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

Using dried blood spot for the detection of HBsAg and anti-HCV antibodies in Cameroon
por: Kenmoe, Sebastien, et al.
Publicado: (2018)

Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
por: Nguyen, Truong Tam, et al.
Publicado: (2018)

Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
por: Wiesmann, F., et al.
Publicado: (2015)

Impact of storage time in dried blood samples (DBS) and dried plasma samples (DPS) for point-of-care hepatitis C virus (HCV) RNA quantification and HCV core antigen detection
por: Troyano-Hernáez, Paloma, et al.
Publicado: (2023)

Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples – a systematic review and meta-analysis
por: Lange, Berit, et al.
Publicado: (2017)

The performance of hepatitis C virus (HCV) antibody point‐of‐care tests on oral fluid or whole blood and dried blood spot testing for HCV serology and viral load among individuals at higher risk for HCV in South Africa
por: Prabdial‐Sing, Nishi, et al.
Publicado: (2021)

903 Protein Saver cards: the best alternative for dried blood spot storage at room temperature for HCV RNA
por: Arca-Lafuente, Sonia, et al.
Publicado: (2022)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania
por: Mohamed, Zameer, et al.
Publicado: (2017)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

Evaluation of the bioMérieux VIDAS HIV Duo Quick and Anti-HCV assays for dried blood spot based serosurveillance
por: Cholette, François, et al.
Publicado: (2022)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

Serum IP-10 Levels Correlate with the Severity of Liver Histopathology in Patients Infected with Genotype-1 HCV
por: You, Chan Ran, et al.
Publicado: (2011)

Identification of novel neutralizing determinants for protection against HCV
por: Alzua, Garazi P., et al.
Publicado: (2023)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
por: Wang, Yuhan, et al.
Publicado: (2021)

HCV resistance
por: Halfon, Philippe
Publicado: (2012)

HCV and Lymphoproliferation
por: Zignego, Anna Linda, et al.
Publicado: (2012)

HCV Diagnosis and Sequencing Using Dried Blood Spots from Patients in Kinshasa (DRC): A Tool to Achieve WHO 2030 Targets
por: Carrasco, Teresa, et al.
Publicado: (2021)

Association of HCV Core Antigen Seropositivity with Long-Term Mortality in Patients on Regular Hemodialysis
por: Kato, Akihiko, et al.
Publicado: (2012)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study
por: Hullegie, Sebastiaan J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2c5dcpbdm1damm49igqca1rdcf